STELLAPHARM J.V. CO., LTD. – BRANCH 1
ActiveSTELLAPHARM J.V. CO., LTD. – BRANCH 1
ActiveSTELLAPHARM J.V. CO., LTD. – BRANCH 1
ActiveSummary
STELLAPHARM J.V. CO., LTD – BRANCH 1 (Công ty TNHH Liên Doanh Stellapharm – Chi nhánh 1) is one of Vietnam’s most active pharmaceutical manufacturing units, operating at No. 40, Tự Do Boulevard, VSIP Bình Dương, where the country’s pharmaceutical industrial base has rapidly expanded. With more than 750 employees, the branch plays a crucial role in supplying pharmaceuticals and functional foods for both domestic distribution and export channels.
Reveals a mixed but dynamic profile. Despite a slight drop in total assets to USD 84.93 million in 2023, sales increased to USD 95.67 million, while profit rose sharply by 15.47%, reaching USD 22.88 million. However, equity contracted significantly by 34.99%, a signal that warrants deeper analysis for investors, lenders, and procurement teams monitoring long-term financial resilience.
Legally, the branch operates under Business ID 0302737671-001 and is wholly owned by Stellapharm J.V. Co., Ltd, an established FDI pharmaceutical producer. The governance is centralized under its Chief of Branch, ensuring streamlined decision-making and compliance across complex production lines—from pharmaceutical formulations to botanical and medicinal chemical products.
With Vietnam’s healthcare sector modernizing and regulatory frameworks tightening, STELLAPHARM Branch 1stands at an essential intersection of opportunity and operational challenge. Stakeholders seeking more profound insights into supply chain stability, financial capacity, or compliance indicators can access the full, continually updated report on VNBIS, where real-time data and verified corporate records provide a clearer picture beyond public disclosures.
Legal Profile
Contacts
Business Sector
Key business lines:
Industry Sales Growth
-2.80%
-5.39%
Companies by industry
1,859
0.0639%
Key Industry Players
Payment History
Financial Performance
| Assets | -38.94% |
| Owner’s Equity | 94.08% |
| Working Capital | 91.08% |
| Net Worth | 2.75% |
| Sales | -91.67% |
| Operating income | -39.39% |
| EBIT | 71.20% |
| Gross Profit Margin | -36.88% |
| Debt to EBITDA | -64.61% |